In this study, we demonstrate decreased plasma apoM concentrations in SLE patients with active disease, most pronounced in patients with renal and skin involvement, and in patients with presence of anti-dsDNA antibodies. The gene discussed is APOM; the disease is systemic lupus erythematosus.